Denileukin diftitox - Eisai
At a glance
- Drug Originator Ajinomoto; Japanese Foundation for Cancer Research
- Drug Licenced by Citius Oncology; Eisai Co Ltd; TSD Japan
- Drug Class ADP ribose transferases; Anti-inflammatories; Antineoplastics; Antipsoriatics; Antiretrovirals; Antirheumatics; Bacterial toxins; Interleukins; Recombinant fusion proteins; Skin disorder therapies
- Mechanism of Action Protein synthesis inhibitors
- USA Patent Applicants EISAI INC
- USA Patents 125
- BLAs 1
- International Patents 1,132

Disclaimer